Brady Johnson, Vice President, Finance at Cidara Therapeutics, Inc. (CDTX), sold 945 shares at $0.71 ($671) on 2022-03-11, disclosed to the SEC on 2022-03-11.
Open-market sale of $671 CDTX by Vice President, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |